PEB

Pacific Edge Limited

AU Healthcare Diagnostics & Research

Latest week
10 Jul 2026
Close
0.245000
Fair value
0.119478
Next-week expectancy
Negative 34.07%
Sharemaestro

PEB Chart Pack

Pacific Edge Limited

Exchange
ASX
Latest week
10 Jul 2026
Close
0.245000
Fair value
0.119478
Next-week expectancy
Negative 34.07%
Generated
16 Jul 2026 20:21
Sector
Healthcare
Industry
Diagnostics & Research

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, PEB rose 63.33%, moving from 0.15 to 0.24. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 9 of the last 12 weeks. Relative Strength is 50.25 and has improved across the 12-week window. Market Dynamics is 1.01 on the latest week. Next-week expectancy is negative at 34.07% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
0.24
12-Week Change
63.33%
Trend Signal
Active
Next-Week Expectancy
Negative 34.07%
Signal Weeks
9 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
50.25
Market Dynamics
1.01

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
0.24
12-Week Change
63.33%
Trend Signal
Active
Next-Week Expectancy
Negative 34.07%
Signal Weeks
9 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
50.25
Market Dynamics
1.01

Over the latest 12 completed weeks ending 2026-07-10, PEB rose 63.33%, moving from 0.15 to 0.24. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 9 of the last 12 weeks. Relative Strength is 50.25 and has improved across the 12-week window. Market Dynamics is 1.01 on the latest week. Next-week expectancy is negative at 34.07% based on similar historical setup states.

Industry Peers

Australia equities in Diagnostics & Research

Stock Exchange Week Open High Low Close Change
MAP Microba Life Sciences Limited ASX 10 Jul 2026 0.04 0.04 0.04 0.04 5.13%
IBX Imagion Biosystems Limited ASX 10 Jul 2026 0.01 0.01 0.01 0.01 4.35%
BDX BCAL Diagnostics Limited ASX 10 Jul 2026 0.07 0.07 0.07 0.07 2.82%
HLS Healius Limited ASX 10 Jul 2026 0.38 0.40 0.37 0.39 2.67%
IDX Integral Diagnostics Limited ASX 10 Jul 2026 2.02 2.12 2.01 2.06 1.98%
MVF Monash IVF Group Limited ASX 10 Jul 2026 0.71 0.72 0.70 0.72 0.70%
SHL Sonic Healthcare Limited ASX 10 Jul 2026 21.19 21.96 20.99 21.24 0.24%
ACL Australian Clinical Labs Limited ASX 10 Jul 2026 2.22 2.31 2.19 2.22 0.00%
CTE Cryosite Limited ASX 10 Jul 2026 1.25 1.25 1.25 1.25 0.00%
RHY Rhythm Biosciences Limited ASX 10 Jul 2026 0.10 0.10 0.09 0.09 -4.21%
GSS Genetic Signatures Limited ASX 10 Jul 2026 0.07 0.07 0.06 0.06 -5.88%
IIQ INOVIQ Ltd ASX 10 Jul 2026 0.25 0.26 0.21 0.22 -12.00%
IME ImExHS Limited ASX 10 Jul 2026 0.35 0.35 0.28 0.29 -17.39%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.